Scientist – Biology, In vivo, Oncology models vacancy for our Basel based client in the Pharma sector.

Your tasks:

• Develop and characterise in vivo oncology models to support preclinical radioligand therapy research.
• Conduct efficacy studies for novel radioligand therapies across oncology programmes.
• Perform biodistribution studies and metabolite analyses to inform pharmacology decisions.
• Carry out small-animal PET, SPECT and CT imaging studies and support image analysis.
• Support laboratory-based in vitro and ex vivo activities such as cell culture, flow cytometry, immunohistochemistry, immunofluorescence, autoradiography, PCR and Western blotting.

Your experience/knowledge:

• Degree in Cell Biology, Medical Physics, Bioengineering, Biotechnology, Pharmacology or a related discipline.
• Practical hands-on experience with rodent handling and in vivo oncology models, including dosing, sampling and animal welfare requirements.
• Experience gained in an academic or industrial biomedical research laboratory.
• Training and practical experience working safely with open radioactive sources.
• Experience with PET, SPECT or CT imaging in rodents and subsequent image analysis is an advantage.
• Language skills: English

Location: Basel, Switzerland
Work setting: On-site
Sector: Pharma
Start: 01/2027
Duration: 24+ months
Workload: 100%
Ref.Nr.: BH 24827

Take the next step and send us your resume along with a daytime phone number where we can reach you.

Due to Swiss work permit restrictions, we can only consider applications from Swiss nationals, EU citizens, and current work-permit holders for Switzerland.

We welcome applications from individuals of all genders, age groups, sexual orientations, personal expressions, ethnic backgrounds, and religious beliefs. Therefore, there is no requirement to provide gender information or a photo in your application.

As per client requirements, we need information about your marital status, nationality, date of birth, and a valid Swiss work permit. For applicants with disabilities, we are happy to explore potential solutions with our end client.